An artesunate-containing antimalarial treatment regimen did not suppress cytomegalovirus viremia.

Publication Type:

Journal Article


Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology (2013)


2013, Center-Authored Paper, Clinical Research Division, July 2013, Public Health Sciences Division, Vaccine and Infectious Disease Division


Additional drugs are needed for the treatment of cytomegalovirus (CMV) infection. Artesunate is an antimalarial drug that has activity against CMV in vitro and in a rodent model. Only a small number of case reports are available describing the clinical effects of artesunate on CMV infection, and these yielded inconsistent results.